Phage-Encoded Proteins Found to Trigger Bacterial DNA Self-Destruction Through the Hna Immune System
As bacteriophages and bacteria continue their evolutionary arms race, researchers are uncovering increasingly sophisticated defense strategies used by microbial cells to survive viral infection. A new study published in Nature Communications reveals how a bacterial anti-phage defense system known as Hna can be directly activated by proteins encoded by invading phages, triggering a destructive immune response based on uncontrolled DNA degradation.
The work, conducted by researchers at the University of Texas at Austin, provides one of the clearest mechanistic descriptions to date of how abortive infection systems function at the molecular level. Unlike classical bacterial immune systems such as CRISPR-Cas or restriction-modification complexes, abortive infection systems do not necessarily aim to save the infected bacterium itself. Instead, they sacrifice the infected cell to prevent viral replication and protect the surrounding bacterial population.
The Hna system, originally identified in Sinorhizobium meliloti, belongs to a relatively rare but broadly distributed family of anti-phage systems found in approximately 2% of sequenced bacterial genomes. The protein contains both helicase-like ATPase domains and a nuclease domain, suggesting a dual role in DNA sensing and degradation. Until now, however, the precise mechanism governing its activation remained unclear.
Using a combination of cryo-electron microscopy, biochemical assays and single-molecule fluorescence imaging, the researchers demonstrated that Hna functions primarily as a 3′–5′ single-stranded DNA exonuclease. Under normal physiological conditions, the protein remains largely inactive because ATP binding promotes the formation of an auto-inhibited homodimer. In this conformation, the nuclease domains become structurally destabilized and DNA degradation is suppressed, preventing accidental toxicity to the bacterial host.
The study shows that this inhibition can be disrupted by phage-encoded single-stranded DNA-binding proteins, particularly a viral protein called 5A SSB. When introduced during infection, the phage protein interacts directly with Hna, destabilizing the inhibitory dimer and shifting the enzyme toward an active nuclease state. Once activated, Hna begins aggressive DNA degradation that likely contributes to host-cell death and interruption of phage replication.
Importantly, the authors observed that mutations within the viral SSB protein allowed certain escape phages to evade Hna detection. These mutant proteins displayed stronger affinity for viral DNA and formed alternative oligomeric structures that reduced productive interaction with Hna. This finding illustrates how bacteriophages can evolve counter-defense mechanisms against bacterial immunity, adding another layer to the complex evolutionary conflict between phages and their hosts.
Beyond its implications for bacterial immunity, the study also highlights an unusual biochemical principle described as kinetic partitioning. Hna appears to balance ATPase activity and nuclease activity through competition for magnesium ions and conformational regulation. Small perturbations in this equilibrium dramatically alter enzyme behavior, either suppressing DNA cleavage or triggering toxic hyperactivity. The authors suggest that this mechanism may represent a broader strategy used by bacterial defense systems to finely tune immune activation while minimizing self-inflicted damage.
The findings contribute to a growing body of evidence showing that phage proteins themselves can act as molecular triggers for bacterial immune systems. Similar mechanisms have recently been identified in systems such as Hachiman, Gabija and retron-associated defenses, suggesting that bacteria may actively monitor conserved viral proteins rather than relying solely on detection of foreign nucleic acids.
As interest in phage biology and antibacterial defense systems accelerates, studies like this continue to expand our understanding of microbial immunity at the structural and mechanistic levels. The work may also influence future biotechnological applications involving programmable nucleases, synthetic immunity platforms and engineered bacteriophage therapies.
.png){kind=logo}
Comments
Post a Comment